Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cura Medical is a specialized medical device company headquartered in the Netherlands, focusing on the production of bio-absorbable hemostats for surgical use. The company is best known for its Curaspon and Curacel product lines, which utilize gelatin and oxidized regenerated cellulose to manage bleeding in various clinical settings. With a strong emphasis on quality, Cura Medical maintains ISO 13485 certification and operates its own GMP-compliant manufacturing facilities. Their products are distributed internationally, serving surgical specialties such as neurosurgery, cardiovascular surgery, and orthopedics. The company remains a key player in the niche market of absorbable surgical materials, providing reliable solutions for intraoperative wound management.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cura Medical.